Effects of ApoE isoforms on beta-amyloid-induced matrix metalloproteinase-9 in rat astrocytes

被引:29
作者
Guo, Shuzhen
Wang, Sophia
Kim, Woo Jean
Lee, Sun-Ryung
Frosch, Matthew P.
Bacskai, Brian J.
Greenberg, Steven M.
Lo, Eng H. [1 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA
[2] Massachusetts Gen Hosp, Dept Radiol, Charlestown, MA USA
[3] Massachusetts Gen Hosp, Alzheimers Dis Res Unit, Charlestown, MA USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] Jeju Natl Univ, Cheju, South Korea
关键词
Alzheimer's disease; proteolysis; ApoE;
D O I
10.1016/j.brainres.2006.06.041
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Matrix metalloproteinase-9 (MMP-9) may play a role in the inflammatory glial response during Alzheimer's disease (AD). Astrocytes can degrade beta-amyloid (A beta) and extracellular proteolysis via MMP-9 may be involved. Because Apolipoprotein E (APOE) genotype is an important factor for AD, we ask whether various apoE isoforms can influence A beta-induced MMP-9 responses in primary rat astrocytes. Our data show that apoE4 significantly dampens A beta-induced MMP-9 levels, possibly by downregulating the Rho-Rho kinase (ROCK) pathway. Reduction of astrocytic MMP-9 by apoE4 may affect A beta clearance and promote A beta deposition in AD. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 32 条
[1]   Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes [J].
Arai, K ;
Lee, SR ;
Lo, EH .
GLIA, 2003, 43 (03) :254-264
[2]  
Asahina M, 2001, CLIN NEUROPATHOL, V20, P60
[3]  
Backstrom JR, 1996, J NEUROSCI, V16, P7910
[4]   Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease [J].
Bales, KR ;
Verina, T ;
Cummins, DJ ;
Du, YS ;
Dodel, TC ;
Saura, J ;
Fishman, CE ;
DeLong, CA ;
Piccardo, P ;
Petegnief, V ;
Ghetti, B ;
Paul, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15233-15238
[5]   PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE [J].
CORDER, EH ;
SAUNDERS, AM ;
RISCH, NJ ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
RIMMLER, JB ;
LOCKE, PA ;
CONNEALLY, PM ;
SCHMADER, KE ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
NATURE GENETICS, 1994, 7 (02) :180-184
[6]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[7]  
Deb S, 1996, J NEUROCHEM, V66, P1641
[8]   Gene delivery of human apolipoprotein E alters brain Aβ burden in a mouse model of Alzheimer's disease [J].
Dodart, JC ;
Marr, RA ;
Koistinaho, M ;
Gregersen, BM ;
Malkani, S ;
Verma, IM ;
Paul, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (04) :1211-1216
[9]   Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease [J].
Fagan, AM ;
Watson, M ;
Parsadanian, M ;
Bales, KR ;
Paul, SM ;
Holtzman, DM .
NEUROBIOLOGY OF DISEASE, 2002, 9 (03) :305-318
[10]  
Fagan AM, 2000, MICROSC RES TECHNIQ, V50, P297, DOI 10.1002/1097-0029(20000815)50:4<297::AID-JEMT9>3.0.CO